Free Access
| Issue |
Med Sci (Paris)
Volume 20, Number 1, Janvier 2004
|
|
|---|---|---|
| Page(s) | 115 - 117 | |
| Section | Perspective/Horizons | |
| DOI | https://doi.org/10.1051/medsci/2004201115 | |
| Published online | 15 January 2004 | |
- Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G, et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000; 288 : 669–72. [Google Scholar]
- Hacein-Bey-Abina S, Le Deist F, Carlier F, et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002; 346 : 1185–93. [Google Scholar]
- Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302 : 415–9. [Google Scholar]
- Howe S, Thrasher AJ. Gene therapy for inherited immunodeficiencies. Curr Hematol Rep 2003; 2 : 328–34. [Google Scholar]
- Aiuti A, Slavin S, Aker M, et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 2002; 296 : 2410–3. [Google Scholar]
- Fischer A, Hacein-Bey S, Cavazzana-Calvo M. Gene therapy of severe combined immunodeficiencies. Nat Rev Immunol 2002; 2 : 615–21. [Google Scholar]
- Wu X, Li Y, Crise B, Burgess SM. Transcription start regions in the human genome are favored targets for MLV integration. Science 2003; 300 : 1749–51. [Google Scholar]
- Li Z, Dullmann J, Schiedlmeier B, et al. Murine leukemia induced by retroviral gene marking. Science 2002; 296 : 497. [Google Scholar]
- Kootstra NA, Verma IM. Gene therapy with viral vectors. Annu Rev Pharmacol Toxicol 2003; 43 : 413–39. [Google Scholar]
- Olivares EC, Hollis RP, Chalberg TW, Meuse L, Kay MA, Calos MP. Site-specific genomic integration produces therapeutic Factor IX levels in mice. Nat Biotechnol 2002; 20 : 1124–8. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.